Testing effectiveness (Phase 2)Study completedNCT03401112
What this trial is testing
IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Who this might be right for
Sickle Cell Disease
Cardurion Pharmaceuticals, Inc. 100